Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
Adult patient with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES.
Virchows Arch. 2023 Jan;482(1):227-244. doi: 10.1007/s00428-022-03414-4. Epub 2022 Oct 11.
A modern view of LGL leukemia.
Marchand T, Lamy T, Loughran TP Jr.
Blood. 2024 Oct 31;144(18):1910-1923. doi: 10.1182/blood.2023021790.
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K.
N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607.
Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK, Curry CV, Allen CE.
Br J Haematol. 2022 Jan;196(1):31-44. doi: 10.1111/bjh.17638. Epub 2021 Jun 24.
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
Bexte T, Botezatu L, Miskey C, Gierschek F, Moter A, Wendel P, Reindl LM, Campe J, Villena-Ossa JF, Gebel V, Stein K, Cathomen T, Cremer A, Wels WS, Hudecek M, Ivics Z, Ullrich E.
Mol Ther. 2024 Jul 3;32(7):2357-2372. doi: 10.1016/j.ymthe.2024.05.022. Epub 2024 May 14.
Chronic lymphoproliferative disorder of NK cells with TNFAIP3 and DNMT3A mutations.
Bulterys PL, Silva O.
Blood. 2021 Jun 17;137(24):3460. doi: 10.1182/blood.2021011812.
Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD.
Eur J Haematol. 2018 May;100(5):444-454. doi: 10.1111/ejh.13038. Epub 2018 Mar 9.
Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
Fei F, Stehr H, Zehnder JL.
Leuk Lymphoma. 2023 Sep;64(9):1536-1544. doi: 10.1080/10428194.2023.2220450. Epub 2023 Jun 17.
Natural killer-cell neoplasms.
Greer JP, Mosse CA.
Curr Hematol Malig Rep. 2009 Oct;4(4):245-52. doi: 10.1007/s11899-009-0032-3.
NK cell recognition of hematopoietic cells by SLAM-SAP families.
Chen S, Dong Z.
Cell Mol Immunol. 2019 May;16(5):452-459. doi: 10.1038/s41423-019-0222-4. Epub 2019 Mar 25.
